{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:19:39Z","timestamp":1788995979375,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1997,9,2]]},"abstract":"<jats:p>\n            <jats:italic>Background<\/jats:italic>\n            The class Ia antiarrhythmic drug disopyramide relieves the outflow tract obstruction of hypertrophic obstructive cardiomyopathy (HOCM). Disopyramide, however, has several adverse effects, such as dysuria and thirst, resulting from its anticholinergic activity. A new class Ia antiarrhythmic drug, cibenzoline, has little anticholinergic activity. The aim of this study is to elucidate whether cibenzoline attenuates left ventricular pressure gradient (LVPG) in patients with HOCM.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods and Results<\/jats:italic>\n            Ten patients with HOCM (mean age, 59\u00b112 years) participated in this study. LVPG and left ventricular functions were measured before and 2 hours after administration of a single oral dose of 150 or 200 mg cibenzoline. LVPG decreased from 123\u00b160 to 39\u00b133 mm Hg (\n            <jats:italic>P<\/jats:italic>\n            =.0026). The E\/A ratio in transmitral Doppler flow increased from 1.20\u00b10.84 to 2.00\u00b11.72 (\n            <jats:italic>P<\/jats:italic>\n            =.029). Isovolumic relaxation time increased from 73\u00b116 to 101\u00b123 ms (\n            <jats:italic>P<\/jats:italic>\n            =.0026). Left ventricular diastolic dimension remained unchanged, but left ventricular systolic dimension enlarged significantly, from 21.6\u00b12.4 to 26.2\u00b13.3 mm (\n            <jats:italic>P<\/jats:italic>\n            =.0004). Fractional shortening decreased from 47.6\u00b16.1% to 34.6\u00b18.8% (\n            <jats:italic>P<\/jats:italic>\n            =.0007). Left ventricular ejection time index decreased significantly, and preejection period index increased in all the patients. Decreased LVPG remained maintained even in the long-term treatment with cibenzoline.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            These results indicate that cibenzoline can markedly attenuate LVPG in patients with HOCM. A decrease in myocardial contractility seems to be closely related to a marked decrease in LVPG.\n          <\/jats:p>","DOI":"10.1161\/01.cir.96.5.1520","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:41:02Z","timestamp":1339461662000},"page":"1520-1524","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":98,"title":["Class Ia Antiarrhythmic Drug Cibenzoline"],"prefix":"10.1161","volume":"96","author":[{"given":"Mareomi","family":"Hamada","sequence":"first","affiliation":[{"name":"From the Second Department of Internal Medicine, Ehime University School of Medicine, and Internal Medicine, Takanoko Hospital (T.O.), Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shigematsu","sequence":"additional","affiliation":[{"name":"From the Second Department of Internal Medicine, Ehime University School of Medicine, and Internal Medicine, Takanoko Hospital (T.O.), Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Ikeda","sequence":"additional","affiliation":[{"name":"From the Second Department of Internal Medicine, Ehime University School of Medicine, and Internal Medicine, Takanoko Hospital (T.O.), Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hara","sequence":"additional","affiliation":[{"name":"From the Second Department of Internal Medicine, Ehime University School of Medicine, and Internal Medicine, Takanoko Hospital (T.O.), Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Okayama","sequence":"additional","affiliation":[{"name":"From the Second Department of Internal Medicine, Ehime University School of Medicine, and Internal Medicine, Takanoko Hospital (T.O.), Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kodama","sequence":"additional","affiliation":[{"name":"From the Second Department of Internal Medicine, Ehime University School of Medicine, and Internal Medicine, Takanoko Hospital (T.O.), Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Ochi","sequence":"additional","affiliation":[{"name":"From the Second Department of Internal Medicine, Ehime University School of Medicine, and Internal Medicine, Takanoko Hospital (T.O.), Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Hiwada","sequence":"additional","affiliation":[{"name":"From the Second Department of Internal Medicine, Ehime University School of Medicine, and Internal Medicine, Takanoko Hospital (T.O.), Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.4.7923662"},{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Schoendube FA Klues HG Reith S Flachskampf FA Hanrath P Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation. 1995;92(suppl II):II-122-II-127.","DOI":"10.1161\/01.CIR.92.9.122"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91961-7"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.85.6.1350522"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.6.7994815"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198210143071607"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1991.tb01900.x"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00054192"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199002000-00019"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.44.6.672"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(88)90207-0"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1984.tb01834.x"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.230"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.6.1072"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.67.5.6682018"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)91127-1"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.55.417"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(69)90012-5"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb10007.x"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1982.tb09163.x"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)90269-X"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.66.2.7094252"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.69.1.6537786"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(80)90661-4"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.47.522"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.81.1.2297830"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000470339"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Frank MJ Abdulla AM Watkins LO Prisant L Stefadouros MA. Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol. Eur Heart J. 1983;4(suppl F):155-164.","DOI":"10.1093\/eurheartj\/4.suppl_F.155"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.60.6.574066"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.42.1.35"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1986.tb14588.x"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(91)90314-V"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.96.5.1520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:49:47Z","timestamp":1715532587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.96.5.1520"}},"subtitle":["A New Approach to the Medical Treatment of Hypertrophic Obstructive Cardiomyopathy"],"short-title":[],"issued":{"date-parts":[[1997,9,2]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,9,2]]}},"alternative-id":["10.1161\/01.CIR.96.5.1520"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.96.5.1520","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9,2]]},"assertion":[{"value":"1997-01-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-04-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-09-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}